RSS

Karolinska Development

Forendo Pharma — portfolio company of Karolinska Development — has been granted a €3 million loan from Business Finland to support the development of a novel drug for the treatment of endometriosis. more

News

Aprea Therapeutics, Karolinska Development’s portfolio company, has announced a collaboration with Memorial Sloan Kettering Cancer Center to study the effects of reactivation of tumour suppressor protein p53 by APR-246. more

News